Literature DB >> 29192985

Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus.

D F Murrell1, E Sprecher2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29192985     DOI: 10.1111/bjd.15947

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Citrobacter freundii sepsis in an immunosuppressed patient with pemphigus vulgaris.

Authors:  Martina Ferranti; Giulia Tadiotto Cicogna; Andrea Sattin; Mauro Alaibac
Journal:  BMJ Case Rep       Date:  2018-12-17

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 3.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 4.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.